Papers
1
Total Citations
17
H-Index
1
About
Xiaoting Fu is a leading researcher in clinical microbiology and antimicrobial resistance, with a focus on developing rapid, automated diagnostic tools to combat multidrug-resistant pathogens. Her most cited work, the 2022 paper on CAST‑R, introduces an innovative system for automated antimicrobial susceptibility testing (AST) directly from positive blood cultures, using tigecycline for sepsis as a model. This breakthrough dramatically reduces the time and labor traditionally required for AST, offering a reliable, high-throughput solution that accelerates targeted therapy for septic patients. With 17 citations and growing influence, Fu’s contributions address a critical bottleneck in infectious disease management, enabling faster clinical decisions and improved patient outcomes. Her research bridges automation, microbiology, and clinical practice, positioning her as a key figure in the fight against antimicrobial resistance. Fu’s work not only advances diagnostic precision but also holds promise for global health by streamlining resistance surveillance and personalized treatment.
Research Focus
Key Achievements
Top Papers
- 1